These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 35258935)

  • 1. Metal-Enhanced Aggregation-Induced Emission Strategy for the HIV-I RNA-Binding Ligand Assay.
    Li J; Fan YY; Wen J; Zhang J; Zhang ZQ
    Anal Chem; 2022 Mar; 94(11):4695-4702. PubMed ID: 35258935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligand-induced changes in 2-aminopurine fluorescence as a probe for small molecule binding to HIV-1 TAR RNA.
    Bradrick TD; Marino JP
    RNA; 2004 Sep; 10(9):1459-68. PubMed ID: 15273324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Cyclic Mimic of HIV Tat Differentiates Similar TAR RNAs on the Basis of Distinct Dynamic Behaviors.
    Lu J; Nguyen L; Zhao L; Xia T; Qi X
    Biochemistry; 2015 Jun; 54(23):3687-93. PubMed ID: 26016940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discoveries of Tat-TAR interaction inhibitors for HIV-1.
    Yang M
    Curr Drug Targets Infect Disord; 2005 Dec; 5(4):433-44. PubMed ID: 16535863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling of HIV-1 TAR RNA-ligand complexes.
    Mitrasinovic PM; Tomar JS; Nair MS; Barthwal R
    Med Chem; 2011 Jul; 7(4):301-8. PubMed ID: 21574948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HMGA1 directly interacts with TAR to modulate basal and Tat-dependent HIV transcription.
    Eilebrecht S; Wilhelm E; Benecke BJ; Bell B; Benecke AG
    RNA Biol; 2013 Mar; 10(3):436-44. PubMed ID: 23392246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probing interaction of a fluorescent ligand with HIV TAR RNA.
    Qi L; Zhang J; He T; Huo Y; Zhang ZQ
    Spectrochim Acta A Mol Biomol Spectrosc; 2017 Feb; 173():93-98. PubMed ID: 27611591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding sites of the viral RNA element TAR and of TAR mutants for various peptide ligands, probed with LILBID: a new laser mass spectrometry.
    Morgner N; Barth HD; Brutschy B; Scheffer U; Breitung S; Göbel M
    J Am Soc Mass Spectrom; 2008 Nov; 19(11):1600-11. PubMed ID: 18693035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural requirements for conserved Arg52 residue for interaction of the human immunodeficiency virus type 1 trans-activation responsive element with trans-activator of transcription protein (49-57). Capillary electrophoresis mobility shift assay.
    Mucha P; Szyk A; Rekowski P; Barciszewski J
    J Chromatogr A; 2002 Aug; 968(1-2):211-20. PubMed ID: 12236505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of transcription by HIV-1 Tat protein tethered to nascent RNA through another protein.
    Southgate C; Zapp ML; Green MR
    Nature; 1990 Jun; 345(6276):640-2. PubMed ID: 2190099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The structure of the human immunodeficiency virus type-1 TAR RNA reveals principles of RNA recognition by Tat protein.
    Aboul-ela F; Karn J; Varani G
    J Mol Biol; 1995 Oct; 253(2):313-32. PubMed ID: 7563092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conserved nucleotides in the TAR RNA stem of human immunodeficiency virus type 1 are critical for Tat binding and trans activation: model for TAR RNA tertiary structure.
    Delling U; Reid LS; Barnett RW; Ma MY; Climie S; Sumner-Smith M; Sonenberg N
    J Virol; 1992 May; 66(5):3018-25. PubMed ID: 1560535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The RNA element encoded by the trans-activation-responsive region of human immunodeficiency virus type 1 is functional when displaced downstream of the start of transcription.
    Churcher MJ; Lowe AD; Gait MJ; Karn J
    Proc Natl Acad Sci U S A; 1995 Mar; 92(6):2408-12. PubMed ID: 7892280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of a small molecule Tat-trans-activation-responsive RNA antagonist that potently inhibits human immunodeficiency virus-1 replication.
    Hwang S; Tamilarasu N; Kibler K; Cao H; Ali A; Ping YH; Jeang KT; Rana TM
    J Biol Chem; 2003 Oct; 278(40):39092-103. PubMed ID: 12857725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A bulge structure in HIV-1 TAR RNA is required for Tat binding and Tat-mediated trans-activation.
    Roy S; Delling U; Chen CH; Rosen CA; Sonenberg N
    Genes Dev; 1990 Aug; 4(8):1365-73. PubMed ID: 2227414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of human immunodeficiency virus type 1 replication by regulated expression of a polymeric Tat activation response RNA decoy as a strategy for gene therapy in AIDS.
    Lisziewicz J; Sun D; Smythe J; Lusso P; Lori F; Louie A; Markham P; Rossi J; Reitz M; Gallo RC
    Proc Natl Acad Sci U S A; 1993 Sep; 90(17):8000-4. PubMed ID: 8367455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein orientation in the Tat-TAR complex determined by psoralen photocross-linking.
    Wang Z; Wang X; Rana TM
    J Biol Chem; 1996 Jul; 271(29):16995-8. PubMed ID: 8663586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An ultra-high affinity ligand of HIV-1 TAR reveals the RNA structure recognized by P-TEFb.
    Shortridge MD; Wille PT; Jones AN; Davidson A; Bogdanovic J; Arts E; Karn J; Robinson JA; Varani G
    Nucleic Acids Res; 2019 Feb; 47(3):1523-1531. PubMed ID: 30481318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of HIV-1 Tat-dependent trans activation by steric block chimeric 2'-O-methyl/LNA oligoribonucleotides.
    Arzumanov A; Walsh AP; Rajwanshi VK; Kumar R; Wengel J; Gait MJ
    Biochemistry; 2001 Dec; 40(48):14645-54. PubMed ID: 11724578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of neomycin to the TAR element of HIV-1 RNA induces dissociation of Tat protein by an allosteric mechanism.
    Wang S; Huber PW; Cui M; Czarnik AW; Mei HY
    Biochemistry; 1998 Apr; 37(16):5549-57. PubMed ID: 9548939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.